This is the first of a 2-part round-table discussion that brings together the expertise of a dermatologist, medical oncologist, and Mohs surgeon and pairs it with a first-hand account of how Jim, a cutaneous squamous cell carcinoma (cSCC) survivor, and his caregiver navigated the ups and downs of a rapidly-metastatic cSCC diagnosis and treatment labyrinth. In this activity, learners will explore pressing questions regarding the safety and efficacy of new systemic options for managing advanced cSCC not otherwise amenable to curative surgical strategies.
Upon completion of this activity, participants should be better able to:
Associate Professor, Dermatology
Harvard Medical School
Director, Mohs and Dermatologic Surgery Center
Dana-Farber/Brigham and Women’s Cancer Center
Chief, Translational Research and Immunotherapy
Director, Cutaneous Oncology
The Angeles Clinic and Research Institute
Los Angeles, CA
Assistant Professor, Division of Dermatology
Department of Internal Medicine
The University of Texas
Austin Dell Medical School
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources